How Is Prostate Cancer Diagnosed?

This content has been reviewed and approved by

Daniel P. Petrylak, MD
Associate Professor of Medicine
Director, Genitourinary Oncology Program
Columbia University Medical Center
 

To detect cancer in your prostate gland, it is key to get a screening that commonly involves giving a blood sample to measure your PSA (prostate-specific antigen) level and/or getting a digital rectal examination (DRE) of the prostate area from your doctor or health care provider. 

  • PSA is a substance produced by the prostate to make semen a liquid. A PSA blood test measures the level of prostate-specific antigen in your body. Higher amounts of PSA may be found in men who have prostate cancer. 
  • DRE is when a physician or nurse places a gloved lubricated finger into the rectum, examines the area, and feels the prostate gland. During the exam, the physician feels for abnormal shape, size, and texture of the prostate. Although this procedure may make you uneasy, discomfort is generally mild.

As recommended by your physician, PSA tests as well as DREs are usually conducted annually for men over the age of 50. Early detection is important. It can limit the disease or set you on the road to a cure.  If you are over 50, you should have an annual physical examination that includes these tests as well as urine tests and possibly other laboratory tests. 

  • Men in high-risk groups, such as African-Americans or those with a strong family history of prostate cancer, should consult their physicians about having these two tests at a younger age or more often.

If the results of the DRE or PSA are unusual, your physician may repeat the tests or request other procedures. To learn more about these other procedures click on the following link.

Additional Procedures to Identify Prostate Cancer

This content was last modified on August 07, 2007 .
Latest Prostate Cancer News
Japan emperor cancels duties due to irregular pulse

December 3, 2008 — TOKYO (Reuters Life!) - Japanese Emperor Akihito will cancel official duties through Thursday, including a planned meeting with the Polish president, after he was diagnosed with an irregular pulse, the Imperial Household Agency said on Wednesday.

Prostate cancer radiotherapy safe for HIV patients

December 1, 2008 — NEW YORK (Reuters Health) - The results of small study suggest that radiotherapy can be safely used to treat prostate cancer in HIV-infected men. Treatment appears to have no long-term effect on CD4+ cell count or viral load.

Extra testosterone won't boost physical function

November 28, 2008 — NEW YORK (Reuters Health) - Healthy older men who given large doses of testosterone show increases in muscle mass and power, but no improvement in physical function, a new study shows.

Select news items provided by Reuters Health